ArticleClinical breast cancer2025

Real-World Evidence on Prescribing Patterns and Clinical Outcomes of Metastatic Breast Cancer Patients Treated with PARP Inhibitors: The Mayo Clinic Experience.

Nusrat Jahan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.